| CD70 |
CD70 belongs to TNF ligand family and can enhance the generation of cytolytic T cells and induce proliferation of co-stimulated T cells (Keller et al., 2007; Kuka et al., 2013). The regulatory mechanisms for the CD70-CD27 pathway is critical for prognosis of cancer patients. |
| CXorf21 |
CXorf21 is a mediator of the X-chromosome gene of systemic lupus erythematosus in female (Bentham et al., 2015; Harris et al., 2019b) and is expressed only in immune cell (Harris et al., 2019a). |
| CD74 |
CD74 expression serves as a prognostic factor in many cancers (Ekmekcioglu et al., 2016; Otterstrom et al., 2014; Ruvolo et al., 2019; Zeiner et al., 2015; Zeiner et al., 2018; Zhang et al., 2014). |
| RUBCNL |
RUBCNL is a vertebrate-specific autophagy regulator (Cheng et al., 2017), and involves autophagy in NSCLC (Levy, Towers & Thorburn, 2017). |
| BIRC3 |
BIRC3 involves in the prognostication system in Chronic Lymphocytic Leukemia (Alhourani et al., 2016) and hepatocellular carcinoma patients undergoing curative resection (Fu et al., 2019). |
| TESC |
TESC can reinforce the radio-resistant properties of NSCLC (Lee et al., 2018). |
| INSL4 |
Abnormal INSL4 signaling may act as a promising therapeutic target for LKB1-deficient NSCLC (Yang et al., 2018). |
| HLA-DOB |
HLA-DOB are expressed in antigen presenting cells which is tightly linked with the immunity. |
| CIITA |
The vaccination with CIITA-tumour cells is constructed to facilitate anti-tumour cells to enhance the immune system (Accolla et al., 2019). |
| STAP1 |
No relevant report yet. |
| OBP2A |
No relevant report yet. |
